https://scholars.lib.ntu.edu.tw/handle/123456789/584504
標題: | Inherited variants in Wnt pathway genes influence outcomes of prostate cancer patients receiving androgen deprivation therapy | 作者: | Geng J.-H. Lin V.C. Yu C.-C. CHAO-YUAN HUANG Yin H.-L. Chang T.-Y. Lu T.-L. Huang S.-P. Bao B.-Y. |
關鍵字: | Androgen deprivation therapy; Genetic variation; Outcomes; Prostate cancer; Wnt pathway | 公開日期: | 2016 | 出版社: | MDPI AG | 卷: | 17 | 期: | 12 | 起(迄)頁: | 1970 | 來源出版物: | International Journal of Molecular Sciences | 摘要: | Aberrant Wnt signaling has been associated with many types of cancer. However, the association of inherited Wnt pathway variants with clinical outcomes in prostate cancer patients receiving androgen deprivation therapy (ADT) has not been determined. Here, we comprehensively studied the contribution of common single nucleotide polymorphisms (SNPs) in Wnt pathway genes to the clinical outcomes of 465 advanced prostate cancer patients treated with ADT. Two SNPs, adenomatous polyposis coli (APC) rs2707765 and rs497844, were significantly (p ? 0.009 and q ? 0.043) associated with both prostate cancer progression and all-cause mortality, even after multivariate analyses and multiple testing correction. Patients with a greater number of favorable alleles had a longer time to disease progression and better overall survival during ADT (p for trend ? 0.003). Additional, cDNA array and in silico analyses of prostate cancer tissue suggested that rs2707765 affects APC expression, which in turn is correlated with tumor aggressiveness and patient prognosis. This study identifies the influence of inherited variants in the Wnt pathway on the efficacy of ADT and highlights a preclinical rationale for using APC as a prognostic marker in advanced prostate cancer. ? 2016 by the authors; licensee MDPI, Basel, Switzerland. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85000786852&doi=10.3390%2fijms17121970&partnerID=40&md5=04581f7af348b662428d53a2d6cf0f10 https://scholars.lib.ntu.edu.tw/handle/123456789/584504 |
ISSN: | 1661-6596 | DOI: | 10.3390/ijms17121970 | SDG/關鍵字: | APC protein; antiandrogen; antineoplastic hormone agonists and antagonists; androgen deprivation therapy; Article; bioinformatics; cancer mortality; cancer survival; cohort analysis; controlled study; gene expression; gene mutation; genetic variation; human; human tissue; major clinical study; normal human; prostate cancer; protein expression; reverse transcription polymerase chain reaction; single nucleotide polymorphism; treatment outcome; Wnt signaling pathway; colon polyposis; disease course; drug effects; genetics; genotype; male; metabolism; pathology; physiology; prognosis; prostate; prostate tumor; Wnt signaling pathway; Adenomatous Polyposis Coli; Androgen Antagonists; Antineoplastic Agents, Hormonal; Disease Progression; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Prognosis; Prostate; Prostatic Neoplasms; Wnt Signaling Pathway |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。